Bingham McCutchen LLP
Bingham's Life Sciences Industry Group is one of the largest in the country. We represent numerous public and private biotechnology, medical device, pharmaceutical and healthcare services companies in a wide range of activities. We also represent investment banks, venture capitalists and other debt and equity providers investing in the life sciences sector.
Our life science lawyers understand the science and the technologies that drive our clients' businesses. By leveraging our backgrounds in science education, the life sciences industry and the law with our particular understanding of intellectual property, corporate finance, commercial transactions, and litigation, we assist our clients to optimize the return on their investments in research and development.
With more than 1100 lawyers in 12 offices spanning the United States and abroad, Bingham McCutchen focuses on serving clients in high-stakes litigation, complex financing and financial regulatory issues, government affairs, and a wide variety of sophisticated corporate and technology matters.